Hefei TNJ chemical industry co.,ltd
Free supplier Enterprise Certification
- Free
supplier - 10th
years
Free supplier Enterprise Certification
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Trading Company
Tel: 0086-551-65418684
Mobile:
Tel: 0086-551-65418684
Fax: +86-51-65418697
Province/state: Anhui
City: Hefei
Street: B911 Xincheng Business Center, Qianshan Road, Hefei Anhui China
MaxCard:
Contact Suppliers
CAS NO.93106-60-6
Poultry enrofloxacin
1. Basic information
Enrofloxacin base ,93106-60-6
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine
Appearance: Light-yellow or light-yellow orange crystalline powder
Purity: 99% min
2.Introduction
Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.
3.Specification
|
Item |
Standard |
Result |
|
Appearance |
Light-yellow or light-yellow orange crystalline powder |
Light-yellow crystalline Powder |
|
Melting range |
Between 221°C and 226°C |
223.0°C~225.5°C |
|
Identification |
Meet the requirements |
Meet the requirements |
|
Fluoroquinolonic acid |
Not more than 0.2% |
<0.2% |
|
Ciprofloxacin |
Not more than 1.0% |
0.15% |
|
Loss on drying |
Not more than 3.0% |
0.1% |
|
Residue on ignition |
Not more than 0.2% |
0.04% |
|
Heavy metals |
Not more than 20ppm |
<20ppm |
|
Assay(on the dried basis) |
Not less than 98.5% |
99.1% |
4.Application
Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Poultry enrofloxacin
1. Basic information
Enrofloxacin base ,93106-60-6
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine
Appearance: Light-yellow or light-yellow orange crystalline powder
Purity: 99% min
2.Introduction
Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.
3.Specification
|
Item |
Standard |
Result |
|
Appearance |
Light-yellow or light-yellow orange crystalline powder |
Light-yellow crystalline Powder |
|
Melting range |
Between 221°C and 226°C |
223.0°C~225.5°C |
|
Identification |
Meet the requirements |
Meet the requirements |
|
Fluoroquinolonic acid |
Not more than 0.2% |
<0.2% |
|
Ciprofloxacin |
Not more than 1.0% |
0.15% |
|
Loss on drying |
Not more than 3.0% |
0.1% |
|
Residue on ignition |
Not more than 0.2% |
0.04% |
|
Heavy metals |
Not more than 20ppm |
<20ppm |
|
Assay(on the dried basis) |
Not less than 98.5% |
99.1% |
4.Application
Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
